Research

LIke ThisLIke ThisLIke This

Michael Ferguson, MD

Michael Ferguson MD
Department:
Medicine Research
Division
Nephrology Research
Hospital Title:
Director, Hypertension Program and Co-Director of Fellowship Program
Academic Title:
Instructor in Pediatrics, Harvard Medical School
Contact:
617-355-6129
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Publications

Publications powered by Harvard Catalyst Profiles
  1. Johnson PK, Ferguson MA, Zachariah JP. In-Clinic Blood Pressure Prediction of Normal Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Referrals. Congenit Heart Dis. 2016 Jul; 11(4):309-14.
  2. Stein DR, Ferguson MA. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58.
  3. Braun DA, Lawson JA, Gee HY, Halbritter J, Shril S, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Fisher B, Spaneas L, Varner J, Sayer JA, Milosevic D, Baum M, Tasic V, Hildebrandt F. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Clin J Am Soc Nephrol. 2016 Apr 7; 11(4):664-72.
  4. Ferguson MA. Commentary on "protective effect of pulmonary hypertension against right-sided tamponade in pericardial effusion". South Med J. 2015 Jan; 108(1):49-50.
  5. Sternberg JM, Gierlinski M, Biéler S, Ferguson MA, Ndung'u JM. Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Dec; 8(12):e3373.
  6. Miller MH, Walsh SV, Atrih A, Huang JT, Ferguson MA, Dillon JF. Serum proteome of nonalcoholic fatty liver disease: a multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis. J Gastroenterol Hepatol. 2014 Oct; 29(10):1839-47.
  7. Pickett CA, Villines TC, Ferguson MA, Hulten EA. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Am J Cardiol. 2014 Nov 15; 114(10):1584-9.
  8. Pickett CA, Villines TC, Ferguson MA, Hulten EA. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014 Aug; 41(4):357-67.
  9. Sullivan L, Fleming J, Sastry L, Mehlert A, Wall SJ, Ferguson MA. Identification of sVSG117 as an immunodiagnostic antigen and evaluation of a dual-antigen lateral flow test for the diagnosis of human African trypanosomiasis. PLoS Negl Trop Dis. 2014 Jul; 8(7):e2976.
  10. Davis ML, Ferguson MA, Zachariah JP. Clinical predictors and impact of ambulatory blood pressure monitoring in pediatric hypertension referrals. J Am Soc Hypertens. 2014 Sep; 8(9):660-7.
  11. Show all
  12. Porras D, Stein DR, Ferguson MA, Chaudry G, Alomari A, Vakili K, Fishman SJ, Lock JE, Kim HB. Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol. 2013 Oct; 28(10):2023-33.
  13. Ferguson MA, Flynn JT. Rational use of antihypertensive medications in children. Pediatr Nephrol. 2014 Jun; 29(6):979-88.
  14. Vakili K, Fullington NM, Turner CG, Cauley RP, Potanos KM, Lee S, Ferguson M, Lock JE, Kim HB. Aorto-mesenteric and renal allograft transplant: a novel treatment for midaortic syndrome. Am J Transplant. 2013 Apr; 13(4):1088-92.
  15. Kim HB, Vakili K, Modi BP, Ferguson MA, Guillot AP, Potanos KM, Prabhu SP, Fishman SJ. A novel treatment for the midaortic syndrome. N Engl J Med. 2012 Dec 13; 367(24):2361-2.
  16. Taylor ML, Carmona F, Thiagarajan RR, Westgate L, Ferguson MA, del Nido PJ, Rajagopal SK. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013 Jul; 146(1):146-52.
  17. Renella R, Stickney C, Keswani M, Mancuso T, Casavant D, Ferguson M, Narla A. Fulminant thrombotic microangiopathy in pediatrics: where diagnostic and therapeutic dilemmas meet. Am J Hematol. 2012 Aug; 87(8):816-8.
  18. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012 Apr; 58(4):680-9.
  19. Murphy MT, Templeton LJ, Fleming J, Ferguson M, Peterkin M, Fraser RH. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med. 1997 Jun; 7(2):135-41.
  20. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec; 1(3):200-8.
  21. Ferguson MA, Vaidya VS, Bonventre JV. Biomarkers of nephrotoxic acute kidney injury. Toxicology. 2008 Mar 20; 245(3):182-93.
  22. Ferguson MA, Vaidya VS, Waikar SS, Collings FB, Sunderland KE, Gioules CJ, Bonventre JV. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 Apr; 77(8):708-14.
  23. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008; 48:463-93.
  24. Lahiri T, Guillet A, Diehl S, Ferguson M. High-dose ibuprofen is not associated with increased biomarkers of kidney injury in patients with cystic fibrosis. Pediatr Pulmonol. 2014 Feb; 49(2):148-53.
  25. Fleming JR, Sastry L, Crozier TW, Napier GB, Sullivan L, Ferguson MA. Proteomic selection of immunodiagnostic antigens for Trypanosoma congolense. PLoS Negl Trop Dis. 2014 Jun; 8(6):e2936.
  26. Brand S, Norcross NR, Thompson S, Harrison JR, Smith VC, Robinson DA, Torrie LS, McElroy SP, Hallyburton I, Norval S, Scullion P, Stojanovski L, Simeons FR, van Aalten D, Frearson JA, Brenk R, Fairlamb AH, Ferguson MA, Wyatt PG, Gilbert IH, Read KD. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis. J Med Chem. 2014 Dec 11; 57(23):9855-69.
  27. Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F. Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet. 2016 Jun 02; 98(6):1228-34.
LIke ThisLIke ThisLIke This
Close